Skip to Content
Morningstar

Aurora Cannabis Inc ACB

Morningstar Rating
Unlock
Stock XNAS Rating as of
$6.81 +0.39 (6.07%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Cannabis Shares Rally (Again) on Next Incremental Step to Federal Rescheduling

Kristoffer Inton

Shares of Canadian-licensed producers and US multistate operators rallied massively on news that the US Drug Enforcement Administration will proceed with rescheduling cannabis to Schedule III from Schedule I. Schedule I indicates it is considered to have a high potential for abuse and no medical value. In comparison, Schedule III drugs are considered less dangerous, with a lower potential for abuse and having some medical value. We view the April 30 news as the next step in a long process by the Biden administration to relax the current federal prohibition. We view the market reaction as a reflection of how much pressure these stocks have faced rather than any new development.

Read Full Report

Price vs Fair Value

View History
ACB is trading within a range we consider fairly valued.
Price
$6.42
Fair Value
$73.70
Uncertainty
Extreme
1-Star Price
$66.00
5-Star Price
$8.58
Economic Moat
Lqj
Capital Allocation
Fwk

Bulls Say, Bears Say

Bulls

Aurora is now generating consistent positive adjusted EBITDA, so free cash flow is eventual. The need for dilutive share issuances should fall.

Bears

Aurora has repeatedly issued equity at a massive discount to our fair value estimate, diluting existing shareholders and destroying value. There's a risk it'll do it again.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ACB is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$6.42
Day Range
$6.28–6.95
52-Week Range
$2.84–11.50
Bid/Ask
$6.84 / $6.84
Market Cap
$371.41 Mil
Volume/Avg
4.9 Mil / 7.5 Mil

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
1.14
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
—

Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
1,130
Website
https://www.auroramj.com

Competitors

Valuation

View More
Metric
ACB
TLRY
CRON
Price/Earnings (Normalized)
 ———
Price/Book Value
 0.780.450.99
Price/Sales
 1.141.8912.45
Price/Cash Flow
 ———
Price/Earnings
ACB
TLRY
CRON

Financial Strength

Metric
ACB
TLRY
CRON
Quick Ratio
 1.790.9621.68
Current Ratio
 3.791.9222.54
Interest Coverage
 —−4.39—
Quick Ratio
ACB
TLRY
CRON

Profitability

Metric
ACB
TLRY
CRON
Return on Assets (Normalized)
 —−1.42%−0.53%
Return on Equity (Normalized)
 —−1.82%−0.55%
Return on Invested Capital (Normalized)
 —−0.92%−4.90%
Return on Assets
ACB
TLRY
CRON
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ADmsfkjrmVdlm$76.9 Bil
MKKGY
Merck KGaA ADRYghpcflxtxZthjgzj$72.0 Bil
HLN
Haleon PLC ADRJhrxyhzwCnwg$37.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRBbkhlxmkNhvlf$17.8 Bil
VTRS
Viatris IncMpygwmjwlMhx$14.0 Bil
RDY
Dr Reddy's Laboratories Ltd ADRFlbsbbrfPjxb$12.5 Bil
CTLT
Catalent IncQzzfgdrlFtjnr$10.2 Bil
PRGO
Perrigo Co PLCYvgkwypqTjyl$4.2 Bil
CURLF
Curaleaf Holdings IncHrntwwtdNdyc$3.9 Bil
PBH
Prestige Consumer Healthcare IncPlftshlKsydzb$3.5 Bil

Sponsor Center